Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the page, reflecting a minor version bump. This does not modify study information, eligibility criteria, or any user-facing content.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a patch-level update to the published page. This change does not modify study details or user-facing functionality.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedNew help/navigation sections have been added: How to Read a Study Record, Common Questions, and How to Join a Study, and the Intervention/Treatment label has been reformatted. The page now shows Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.5%

- Check30 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5. This appears to be a small maintenance update to the page's documentation rather than a substantive content change.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows revision v3.5.4, indicating a maintenance/update to the page. There are no changes to the trial details or content evident in this revision.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, reflecting a site/software release rather than a change to the underlying clinical trial information.SummaryDifference0.1%

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.